郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers.

期刊：Bioorganic & medicinal chemistry letters发表年份：2009作者：Eric Vieira; Jörg Huwyler; Synèse Jolidon; Frédéric Knoflach; Vincent Mutel; Jürgen Wichmann
阅读更多 →

药效评价Synthesis and pharmacological evaluation of dimeric follicle-stimulating hormone receptor antagonists.

期刊：ChemMedChem发表年份：2009作者：Kimberly M Bonger; Sascha Hoogendoorn; Chris J van Koppen; Cornelis M Timmers; Herman S Overkleeft; Gijsbert A van der Marel
阅读更多 →

药效评价FLIPR assays of intracellular calcium in GPCR drug discovery.

期刊：Methods in molecular biology (Clifton, N.J.)发表年份：2009作者：Kasper B Hansen; Hans Bräuner-Osborne
阅读更多 →

药效评价Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.

期刊：ChemMedChem发表年份：2009作者：Sylvain Célanire; Maikel Wijtmans; Bernard Christophe; Philippe Collart; Iwan de Esch; Donald Dassesse; Christel Delaunoy; Frédéric Denonne; Véronique Durieu; Edith Gelens; Michel Gillard; Bénédicte Lallemand; Yves Lamberty; Florence Lebon; Jean-Mari
阅读更多 →